Sector: Healthcare
Showing 1–100 of 6049 stocks (page 1 of 61).
| Stock | Market Cap | Dividend Yield | P/E Ratio | Dividend Frequency | Years Paying | DGR |
|---|---|---|---|---|---|---|
| 0R29.L Intuitive Surgical, Inc. | 5.5 trillion | 0.00% | 1.07 | - | - | - |
| 0KW4.L ResMed Inc. | 3.1 trillion | 1.06% | 0.40 | 3 | 9 | 7% |
| 0KSX.L Quest Diagnostics Incorporated | 2.7 trillion | 1.64% | 0.13 | 4 | 10 | 6% |
| LLY Eli Lilly and Company | 1.1 trillion | 0.52% | 40.76 | 4 | 55 | 16% |
| LLY.DE Eli Lilly and Company | 944.3 billion | 0.62% | 44.18 | 4 | 11 | 12% |
| 0JZ2.L Masimo Corporation | 933.7 billion | 0.00% | 0.45 | - | - | - |
| LLY.SW LILLY ELI | 921.7 billion | 0.75% | 75.02 | 2 | - | - |
| JNJ Johnson & Johnson Champions | 618.8 billion | 2.04% | 28.91 | 4 | 26 | 5% |
| JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG | 618.6 billion | 15.54% | 23.79 | 4 | 4 | - |
| JNJ.DE Johnson & Johnson | 605.5 billion | 2.38% | 28.76 | 4 | 27 | 2% |
| 0QCV.IL AbbVie Inc. | 447.9 billion | 2.39% | 51.23 | - | - | - |
| ABBV.NE AbbVie Inc. | 442.6 billion | 17.73% | 185.26 | 4 | 4 | - |
| ABBV AbbVie Inc. | 435.1 billion | 2.80% | 68.96 | 4 | 14 | 6% |
| 4AB.DE AbbVie Inc. | 430.5 billion | 3.23% | 68.38 | 4 | 11 | 0% |
| ABBV.BA AbbVie Inc. | 414.2 billion | 2.24% | 10.31 | 4 | 6 | 30% |
| NOVC.DE Novo Nordisk A/S | 405.3 billion | 1.06% | 22.93 | 2 | 22 | 12% |
| 0QQ6.L Roche Holding AG | 384.5 billion | 2.64% | 22.66 | 1 | 12 | 1% |
| UNH.DE UnitedHealth Group Incorporated | 378.6 billion | 1.21% | 31.31 | 4 | 19 | 10% |
| UNH UnitedHealth Group Incorporated | 374.8 billion | 2.17% | 31.73 | 4 | 37 | 12% |
| UNH.BA UNITEDHEALTH GROUP INC CEDEAR E | 374.7 billion | 0.00% | 251 | - | - | - |
| 0I3I.L The Cooper Companies, Inc. | 370.6 billion | 0.00% | 0.04 | - | - | - |
| RHHBY Roche Holding AG | 359.6 billion | 2.75% | 22.25 | 1 | 34 | 3% |
| RHHBF Roche Holding AG | 358.4 billion | 2.76% | 23.47 | 2 | 25 | 26% |
| RHHVF Roche Holding AG | 349.5 billion | 2.50% | 21.83 | 1 | 37 | 26% |
| RO.SW Roche Holding AG | 345.3 billion | 2.75% | 21.99 | 1 | 32 | 1% |
| MRK Merck & Co., Inc. | 323.0 billion | 2.58% | 104.74 | 4 | 65 | 6% |
| ROG.SW Roche Holding AG | 315.2 billion | 3.06% | 20.11 | 1 | 32 | 1% |
| AZNCF AstraZeneca PLC | 312.8 billion | 1.56% | 33.46 | 3 | 18 | 24% |
| NVS Novartis AG | 291.3 billion | 3.09% | 23.42 | 1 | 30 | 6% |
| NVSEF Novartis AG | 288.8 billion | 3.12% | 22.62 | 2 | 30 | 5% |
| ZEG.DE AstraZeneca PLC | 288.2 billion | 2.00% | 29.17 | 1 | 26 | 6% |
| 6MK.DE Merck & Co., Inc. | 281.7 billion | 2.87% | 15.71 | 4 | 27 | 3% |
| NOVN.SW Novartis AG | 267.0 billion | 4.03% | 21.04 | 1 | 30 | 4% |
| AZN.ST AstraZeneca PLC | 264.9 billion | 0.20% | 25.51 | 2 | 27 | 4% |
| UNH.NE UnitedHealth Group Inc | 252.6 billion | 3.01% | 14.66 | 4 | 5 | - |
| AZN AstraZeneca PLC | 249.1 billion | 1.97% | 25.40 | 2 | 34 | 2% |
| AMG.DE Amgen Inc. | 223.6 billion | 2.79% | 25.58 | 4 | 16 | 4% |
| AMGN Amgen Inc. | 222.3 billion | 2.42% | 25.51 | 4 | 16 | 8% |
| TMO Thermo Fisher Scientific Inc. | 214.7 billion | 0.31% | 31.06 | 4 | 15 | 14% |
| NOV.DE Novo Nordisk A/S | 210.1 billion | 28.68% | 11.81 | 1 | 25 | 4% |
| NOVO-B.CO Novo Nordisk A/S | 209.6 billion | 3.82% | 11.79 | 1 | 27 | 8% |
| NVO Novo Nordisk A/S | 209.1 billion | 3.80% | 11.67 | 2 | 45 | 26% |
| NONOF Novo Nordisk A/S | 205.5 billion | 24.75% | 11.58 | 1 | 18 | 27% |
| SRTOY Sartorius Stedim Biotech S.A. | 192.3 billion | 0.41% | 59.31 | 1 | 6 | -30% |
| ABT.SW Abbott Laboratories | 192.0 billion | 1.99% | 34.62 | 3 | 26 | 14% |
| TN8.DE Thermo Fisher Scientific Inc. | 187.7 billion | 0.34% | 28.60 | 4 | 10 | 13% |
| 0R0H.L Thermo Fisher Scientific Inc. | 186.4 billion | 0.34% | 26.15 | 4 | 10 | 14% |
| TMO.NE Thermo Fisher Scientific Inc. | 184.4 billion | 0.34% | 28.54 | 4 | 3 | - |
| ABT Abbott Laboratories | 181.6 billion | 2.36% | 32.23 | 4 | 44 | 8% |
| ABL.DE Abbott Laboratories | 177.0 billion | 2.80% | 32.42 | 4 | 19 | 6% |
| GIS.DE Gilead Sciences, Inc. | 170.2 billion | 2.76% | - | 4 | 12 | -1% |
| GILD Gilead Sciences, Inc. | 165.0 billion | 2.42% | - | 4 | 12 | 2% |
| PFE Pfizer Inc. Challengers | 152.5 billion | 6.56% | 35.21 | 4 | 55 | 0% |
| PFE.DE Pfizer Inc. | 150.3 billion | 6.43% | 19.53 | 4 | 27 | -2% |
| PFE.NE Pfizer Inc. | 148.5 billion | 14.14% | 14.81 | 4 | 5 | 15% |
| PFE.F Pfizer Inc. | 148.4 billion | 7.56% | 19.41 | 4 | 17 | 0% |
| 0R2S.L Stryker Corporation | 146.7 billion | 0.89% | 72.89 | 4 | 11 | 7% |
| PFE.BA Pfizer Inc. | 145.5 billion | 0.00% | 2.62 | 4 | 19 | 30% |
| 0R2B.L Danaher Corporation | 144.3 billion | 0.64% | 23.26 | 4 | 11 | 30% |
| DAP.DE Danaher Corporation | 143.9 billion | 0.63% | 41.31 | 5 | 24 | 5% |
| DHR Danaher Corporation | 138.8 billion | 0.73% | 34.14 | 4 | 34 | 10% |
| 0R1F.IL Bristol-Myers Squibb Company | 137.4 billion | 3.55% | 17.23 | - | - | - |
| IUI1.DE Intuitive Surgical, Inc. | 134.3 billion | 0.00% | 42.86 | - | - | - |
| CVS.NE CVS Health Corporation | 132.4 billion | 10.53% | 279.78 | 4 | 4 | - |
| ISRG Intuitive Surgical, Inc. | 130.1 billion | 0.00% | 40.47 | - | - | - |
| BMY Bristol-Myers Squibb Company | 130.0 billion | 3.81% | 14.02 | 4 | 55 | 6% |
| 0Y6X.L Medtronic plc | 129.7 billion | 2.93% | 25.90 | 4 | 13 | 16% |
| SYK Stryker Corporation Champions | 128.9 billion | 1.02% | 35.33 | 4 | 34 | 7% |
| 0J1R.L HCA Healthcare, Inc. | 126.1 billion | 0.68% | 0.21 | 4 | 9 | 16% |
| VRTX Vertex Pharmaceuticals Incorporated | 125.7 billion | 0.00% | 28.91 | - | - | - |
| 0JZU.L McKesson Corporation | 122.7 billion | 0.39% | 136.66 | 4 | 10 | 12% |
| CVS CVS Health Corp. | 122.4 billion | 2.78% | 25.24 | 4 | 42 | 6% |
| BRM.DE Bristol-Myers Squibb Company | 121.4 billion | 4.16% | 17.30 | 4 | 28 | 0% |
| VX1.DE Vertex Pharmaceuticals Incorporated | 119.3 billion | 0.00% | 31.29 | - | - | - |
| SNYNF SANOFI | 118.6 billion | 4.07% | 24.26 | 1 | 17 | 2% |
| EL.PA EssilorLuxottica S.A. | 117.5 billion | 1.80% | 42.58 | 1 | 27 | 16% |
| ANTM Anthem, Inc. | 117.1 billion | 0.85% | 25.82 | 1 | 13 | 14% |
| 0QZU.L Vertex Pharmaceuticals Incorporated | 116.6 billion | 0.00% | 47.90 | - | - | - |
| 2M6.DE Medtronic plc | 116.6 billion | 3.10% | 25.49 | 5 | 19 | -2% |
| MDT Medtronic plc Champions | 110.0 billion | 3.32% | 21.63 | 4 | 45 | 2% |
| SNW.DE Sanofi | 109.3 billion | 0.00% | 19.78 | 1 | 27 | 4% |
| SAN.PA Sanofi | 109.0 billion | 0.00% | 19.78 | 1 | 27 | 4% |
| 0HOY.L Boston Scientific Corporation | 107.2 billion | 0.00% | 136.32 | - | - | - |
| MCK McKesson Corporation | 105.1 billion | 0.37% | 23.58 | 4 | 40 | 13% |
| SNY Sanofi | 104.4 billion | 5.57% | 22.95 | 1 | 24 | 4% |
| GLAXF GSK plc | 103.6 billion | 3.47% | 16.38 | 7 | 23 | 10% |
| GSK GSK plc | 103.2 billion | 3.48% | 16.41 | 4 | 43 | -6% |
| ESLOF ESSILORLUXOTTICA | 102.1 billion | 0.02% | 42.04 | 1 | 16 | 25% |
| 0HRS.L CVS Health Corporation | 102.0 billion | 3.30% | 13.40 | 4 | 10 | 6% |
| CVS.DE CVS Health Corporation | 101.3 billion | 3.31% | 58.34 | 4 | 10 | 3% |
| 4519.T Chugai Pharmaceutical Co., Ltd. | 99.0 billion | 1.38% | 36.36 | 2 | 27 | 30% |
| ESLOY EssilorLuxottica S.A. | 90.9 billion | 2.34% | 31.09 | 1 | 22 | 18% |
| CSLLY CSL Limited | 88.9 billion | 3.15% | 8.20 | 2 | 18 | 7% |
| HCA HCA Healthcare, Inc. | 88.7 billion | 0.73% | 14.03 | 4 | 9 | 14% |
| CGN.DE The Cigna Group | 88.4 billion | 1.79% | 15.96 | 2 | 1 | - |
| ELV Elevance Health Inc. | 84.8 billion | 1.75% | 16.89 | 4 | 20 | 12% |
| GSKN.MX GSK PLC | 84.8 billion | 0.00% | 9.68 | 2 | 16 | -5% |
| 0R2M.L Regeneron Pharmaceuticals, Inc. | 83.6 billion | 0.46% | 11.01 | 4 | 2 | - |
| SOAGY Sartorius Aktiengesellschaft | 78.7 billion | 0.32% | 106.63 | 1 | 6 | - |
| REGN Regeneron Pharmaceuticals, Inc. | 78.3 billion | 0.48% | 18.80 | 4 | 2 | - |